Skip to content

Azithromycin as prophylaxis for Caesarean Delivery

Azithromycin-Based Extended- Spectrum Prophylaxis for Caesarean Delivery: A Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064002
Enrollment
280
Registered
2024-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O860- Infection of obstetric surgical wound

Interventions

Intervention1: Injection azithromycin 500mg along with a 1g cefotaxime injection: Addition of Injection Azithromycin 500mg intravenous along with a 1g injection of Cefotaxime within 1 hour of the surg

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Willing to participate with signed informed consent 2. Maternal age >19 years 3. Women undergoing primary or repeat lower-segment caesarean delivery

Exclusion criteria

Exclusion criteria: 1. Known allergy to cephalosporin or azithromycin 2. Use of antibiotics in the 72 hours prior to caesarean section 3. Chorioamnionitis, or any other active bacterial infection (e.g. pyelonephritis, pneumonia or abscess) at the time of randomization 4. Immunocompromising medical conditions: HIV positive with CD4 count below 200, chronic steroid use, current diagnosis of cancer and/or chemotherapy agent use

Design outcomes

Primary

MeasureTime frame
Rates of surgical site infection within 30 days after delivery: Presence of either superficial or deep incisional surgical-site infection characterized by wound induration and discharge from the wound within 30 days after delivery.Timepoint: 30 days

Secondary

MeasureTime frame
1. Rates of endometritis within 30 days after delivery: Presence of at least two of the following signs with no other recognized cause: fever (temperature of at least 38°C[100.4°F]), abdominal pain, uterine tenderness, or purulent discharge from the uterus within 30 days after delivery. 2. Maternal postpartum readmission or unscheduled visits due to sepsis within 30 days after delivery: Admission to the hospital or unscheduled visit due to SSI or endometritis within 30 days after delivery. 3. An additional antibiotic requirement in the postoperative period: Antibiotic use for any reason including other infections such as UTI and sepsis within 30 days after delivery. 4. Microorganisms identified in wound culture and their sensitivity to antibiotics. 5. Neonatal Intensive Care Unit (NICU) admissions due to neonatal sepsis within 30 days.Timepoint: 30 days

Countries

India

Contacts

Public ContactGarima wadhwa

Aiims New Delhi

soniyakvs@gmail.com8126399907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026